Because our work helps make global health responses more efficient, more effective and – most importantly – ensures people in low- and middle-income countries have access to the highest quality health products out there.
Because our work helps make global health responses more efficient, more effective and – most importantly – ensures people in low- and middle-income countries have access to the highest quality health products out there.
Every year, 390 million people use health products we have supported.
Since 2006, we have introduced more than 150 groundbreaking interventions.
Our approach helps reach global health targets three years faster.
By 2030, our work is estimated to generate $US 10 billion in savings.
This is according to an independent modelling exercise, commissioned to understand the overall health and economic impact of our investments in innovative health products. Looking at sixteen key products across four disease areas – HIV, tuberculosis, malaria and hepatitis C – the analysis estimated the value of our contribution to scaling up access to these products in low- and middle-income countries. The analysis found that for every US$1 invested in health innovations, US$46 are saved.
Importantly, we don’t only invest in products with the highest financial return. Many of the innovations we support are designed to reach communities that markets often overlook—such as children, pregnant women, or people in remote or underserved settings. These products may be more costly to scale, or their benefits harder to quantify in purely economic terms. But they are essential to building fairer, more inclusive health systems—and to ensuring that no one is left behind.
Download the technical appendix, for more information.
We take a close look at global disease responses to understand why certain medicines, tests and other health products may not be reaching everywhere they are needed and where new interventions could help fill gaps. Then we tackle the barriers that restrict access – often working across several parts of the problem at the same time – so high-quality care can reach as widely as possible.
Access to innovation is at the heart of our work. Find out more about the critical global health tools and strategies we support.
From daily pills to the latest long-acting technologies, we're working to expand access to a range of options for HIV prevention.
An enhanced intervention against malaria to combat mosquitoes resistant to insecticides used on conventional nets
Tools for detecting, preventing and treating the leading causes of death in childbirth.
Drug formulations for treating children with tuberculosis, HIV, malaria and more.
